Basics AquaBounty Technologies, Inc. AquaBounty Technologies Inc is a biotechnology company. The company is engaged in the business of conducting research and development of the commercial viability of a group of proteins known as antifreeze proteins. IPO Date: January 9, 2017 Sector: Healthcare Industry: Biotech Market Cap: $3.21M Activated in VL: True Average Daily Range Avg Daily Range: $0.13 | 3.95% Avg Daily Range (30 D): $0.04 | 4.81% Avg Daily Range (90 D): $0.03 | 4.23% Institutional Daily Volume Avg Daily Volume: .49M Avg Daily Volume (30 D): .32M Avg Daily Volume (90 D): .65M Trade Size Avg Trade Size (Sh.): 191 Avg Trade Size (Sh.) (30 D): 307 Avg Trade Size (Sh.) (90 D): 389 Institutional Trades Total Inst.Trades: 125 Avg Inst. Trade: $1.52M Avg Inst. Trade (30 D): $.52M Avg Inst. Trade (90 D): $.52M Avg Inst. Trade Volume: .01M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.13M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 21.76K     News May 15, 2024 @ 2:20 PM AquaBounty Technologies, Inc. (AQB) Reports Q1 Los... Source: Zacks Equity Research May 14, 2024 @ 1:10 PM Immunome, Inc. (IMNM) Reports Q1 Loss, Misses Reve... Source: Zacks Equity Research May 13, 2024 @ 9:10 PM Cara Therapeutics (CARA) Reports Q1 Loss, Misses R... Source: Zacks Equity Research May 8, 2024 @ 9:45 PM Arcus Biosciences, Inc. (RCUS) Reports Q1 Loss, To... Source: Zacks Equity Research Oct 16, 2023 @ 12:47 PM Why ContraFect Shares Are Trading Higher By Around... Source: Lisa Levin Financials   TTM Q1 2025 Q4 2024 Basic EPS $-35.64 $.1 $-21.78 Diluted EPS $-35.64 $.1 $-21.78 Revenue $ -.48M $ M $ -.71M Gross Profit $ $ $ Net Income / Loss $ -137.63M $ .4M $ -84.12M Operating Income / Loss $ -101.75M $ -1.26M $ -48.61M Cost of Revenue $ $ $ Net Cash Flow $ -2.23M $ 1.14M $ -.27M PE Ratio     Splits Oct 16, 2023:   1:20 Jan 05, 2017:   1:30